Swiss Top Stock Picks from Analysts

SIG Group

Market Cap: CHF 3.3b

Provides aseptic carton packaging systems and solutions for beverage and liquid food products.

SKAN Group

Market Cap: CHF 1.2b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

naturenergie holding

Market Cap: CHF 1.1b

Through its subsidiaries, engages in the production, distribution, and sale of electricity under the naturenergie brand in Switzerland and internationally.

LEM Holding

Market Cap: CHF 592.0m

Provides solutions for measuring electrical parameters in China, Japan, South Korea, India, Southeast Asia, Europe, the Middle East, Africa, NAFTA and Latin America.

Basilea Pharmaceutica

Market Cap: CHF 568.3m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Vetropack Holding

Market Cap: CHF 461.9m

Provides glass packaging products for the food and beverage industry.

Schweiter Technologies

Market Cap: CHF 428.1m

Develops, produces, and sells composite materials and solutions in lightweight construction in Europe, the Americas, Asia, and internationally.

medmix

Market Cap: CHF 393.2m

Designs, produces, and sells high-precision devices and services in Switzerland and internationally.

Komax Holding

Market Cap: CHF 377.6m

Engages in the automated wire processing business in Europe, North America, South America, the Asia/Pacific, and Africa.

DocMorris

Market Cap: CHF 286.4m

Operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally.

Newron Pharmaceuticals

Market Cap: CHF 217.6m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

BioVersys

Market Cap: CHF 169.5m

A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.

Santhera Pharmaceuticals Holding

Market Cap: CHF 141.6m

A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

Carlo Gavazzi Holding

Market Cap: CHF 115.8m

Designs, manufactures, and sells electronic control components for building and industrial automation markets.

Molecular Partners

Market Cap: CHF 106.6m

A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.

Curatis Holding

Market Cap: CHF 66.1m

Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.

Rieter Holding

Market Cap: CHF 35.6m

Supplies systems for manufacturing yarn from staple fibers in spinning mills in Switzerland and internationally.

Asmallworld

Market Cap: CHF 13.0m

Operates a digital travel and lifestyle ecosystem worldwide.

Addex Therapeutics

Market Cap: CHF 6.7m

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.

Swiss Estates

Market Cap: CHF 6.5m

Engages in investing in the real estate properties in Switzerland.